Manufacturing of clinical supplies up to commercial quantities of APIs, formulations, and complete products for inhalation and nasal dosage forms, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), inhalation solutions, and nasal sprays
As a leading global drug-device combination product CDMO, Kindeva Drug Delivery provides full-service support for pulmonary & nasal products. Backed by over half a century of experience, industry-leading capacity, and unmatched capabilities, we help streamline your first-in-human timeline, minimize risk, and maximize success. Our pulmonary & nasal platform technologies span delivery platforms including pMDIs, DPIs, SMIs, nebulizers, and nasal sprays with additional expertise in green propellants, inhaled biologics, and generic products. Combine forces with us to discover proactive, informed solutions and a collaborative approach to your product’s development and manufacturing needs. Reach out to explore our pulmonary & nasal capabilities.
Recipharm offers integrated services to support inhalation and nasal drug delivery; from initial combination device design, to formulation development, through to manufacturing. Our solutions span across the full product lifecycle, to help provide drug delivery devices to patients globally. These include pressurised metered dose inhalers (pMDIs), soft mist inhalers (SMIs) and multi dose and single dose nasal spray devices. Our experts have extensive knowledge throughout the entire lifecycle of drug product development to market, as well as accelerating routes to market. Recipharm is your true expert CDMO partner for integrated inhalation and nasal platform offerings.
With more than 30 years of experience in supporting the development of inhaled products, and full commercial scale manufacturing capabilities for drug products across DPIs and unit or bi-dose nasal sprays and powders, Catalent offers comprehensive and integrated solutions to accelerate, de-risk and simplify the path to market. From pre-formulation feasibility, device selection and clinical supply to commercial filling, packaging and final product testing, our inhalation team provides scalable solutions to support your molecule at any stage in development.
Vectura helps customers succeed in bringing their inhaled medicines to market with a unique combination of formulation science, device technology and inhaled product development expertise. From one-off studies and specialist techniques through to full development services, we help customers, ranging from small biotech to large pharmaceutical companies, progress their inhaled programmes at every stage of development. With more than 20 years’ experience, we have a rich scientific heritage and reputation for delivering success for our customers, with leading formulation and device technologies across a range of platforms: dry powder inhalers (DPIs), pressurised metered dose inhalers (pMDIs) and smart nebulisers.
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.